ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.

Catherine M Bollard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.